Skip to main content
. 2021 Oct 14;22(6):832. doi: 10.3892/ol.2021.13093

Figure 7.

Figure 7.

Schematic diagram of the molecular mechanism underlying inhibition of HER-2-positive breast cancer cell viability by delphinidin. HER, epidermal growth factor receptor.